NCT06692140Recruiting
Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated With Percutaneous Coronary Intervention
Randomized Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated With Percutaneous Coronary Intervention in an All Comer Population (The SORT OUT XII Trial)
Source: ClinicalTrials.gov · Last updated 22 Oct 2026
Brief summary (registry, in English)
The objective of this randomized study is to compare the safety and efficacy of the ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent to the everolimus-eluting family stents (durable polymer everolimus-eluting Xience or Promus stents) in a population-based setting with coronary artery stenosis treated with percutaneous coronary intervention
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 3150 (estimated)
- First submitted
- 12 Nov 2024
- Start date
- 16 Nov 2024
- Primary completion date
- 1 Jul 2028
- Lead sponsor
- Odense University Hospital
- Diseases
- Coronary artery disease
- NCT number
- NCT06692140
What you commit to
- Study type: Interventional
- Planned participants: 3150
- From 16 Nov 2024 to the primary completion date, 1 Jul 2028
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Allergic to study related treatment
Age
- Age \< 18 years
Other
- Not able to consent to study participating (eg. intubated patients)
- Unstable circuit or in cardiogenic shock and therefore not able to understand the information and purpose of the study
- Do not speak Danish
- Already included in the SORT OUT XII study
- Life expectancy \<1 year
Who the study is looking for
- All patients aged ≥18 years who are eligible for treatment with one or several drug-eluting coronary stents
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aalborg University Hospital Coordinator of this site? Confirm its status | Aalborg | Denmark | Recruiting |
| Aarhus University Hospital Coordinator of this site? Confirm its status | Aarhus | Denmark | Recruiting |
| Odense University Hospital Coordinator of this site? Confirm its status | Odense | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.